Oncolytics Biotech Inc
(ONCY)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2006 | 09-2006 | 06-2006 | 03-2006 | 12-2005 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 3,490 | 3,950 | 7,220 | 6,440 | 3,510 |
| Marketable Securities | 24,120 | 27,530 | 27,270 | 31,240 | 36,890 |
| Receivables | 80 | 30 | 50 | 110 | 40 |
| Other current assets | 640 | 1,250 | 1,010 | 540 | 550 |
| TOTAL | $28,330 | $32,760 | $35,550 | $38,330 | $40,990 |
| Non-Current Assets | |||||
| Other Non-Current Assets | 5,080 | 5,060 | 5,110 | 5,150 | 5,110 |
| TOTAL | $5,080 | $5,060 | $5,110 | $5,150 | $5,110 |
| Total Assets | $33,560 | $37,980 | $40,820 | $43,660 | $46,290 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 2,610 | 2,360 | 1,900 | 2,010 | 1,690 |
| TOTAL | $2,610 | $2,360 | $1,900 | $2,010 | $1,690 |
| Non-Current Liabilities | |||||
| Long Term Debt | 150 | 150 | 150 | 150 | 150 |
| TOTAL | $150 | $150 | $150 | $150 | $150 |
| Total Liabilities | $2,760 | $2,510 | $2,050 | $2,160 | $1,840 |
| Shareholders' Equity | |||||
| Common Shares | 83,080 | 84,680 | 84,590 | 84,340 | 84,340 |
| Retained earnings | -65,030 | -60,140 | -56,710 | -53,720 | -50,730 |
| Other shareholders' equity | 4,220 | 4,220 | 4,220 | 4,420 | 4,430 |
| TOTAL | $30,790 | $35,460 | $38,770 | $41,490 | $44,450 |
| Total Liabilities And Equity | $33,550 | $37,970 | $40,820 | $43,650 | $46,290 |